Thank you for donating!

You can donate using the following services.

Supporting those affected by Niemann-Pick diseases

NPUK 24th Annual Family Conference & Interactive Workshop

Our 24th Annual Family Conference will be held from the 22nd to the 24th of September 2017, in the beautiful Mercure Haydock Hotel - book your place now!

Explore NPUK

View all

Latest news


Update #17 on the AIDNPC Clinical Programme

The study was recently completed in May 2017. A total of 35 patients were enrolled across 12 sites in 8 countries. The primary objective of the 001 study was to characterize the individual patient’s disease progression profile through clinical, biological and quality-of-life measures recorded prospectively, as well as the historic disease information collected from patient medical records. The 001 study has already provided us with some valuable learnings: The NPC-CSS disease score were completed by patients with a good compliance, the skin biopsies and blood tests have been valuable for development and conformation of biomarkers, and we found that two-thirds of patients were treated with miglustat as part of their standard of care. Once all data have been analysed, we expect to gain insight about biomarkers and how the disease evolves over time in greater detail.

Read more


Route of Administration Preferences Study

There is an opportunity for you to participate in a market research study about Niemann-Pick Type C, conducted by an organization called ApotheCom on behalf of an industry sponsor.

The goal of the study is to understand your preferences and concerns regarding the method through which a drug could be administered to manage Niemann-Pick Type C.

Read more
View all news Subscribe